EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping

Sebastian A H van den Wildenberg, Sylvia A A M Genet, Alexander S Streng, Maarten A C Broeren, Maarten J Deenen, Joost L J van Dongen, Luc Brunsveld, Volkher Scharnhorst, Daan van de Kerkhof

Journal of Pharmaceutical and Biomedical Analysis · 2024-10 · 249 · 116381

DOI: 10.1016/j.jpba.2024.116381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2024-10. Verfasst von Sebastian A H van den Wildenberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology, department of Biomedical Engineering, Eindhoven University of Technology, the Netherlands; Clinical Laboratory, Catha…. Hauptthemen laut MEDLINE: Thymine, Uracil, Dihydrouracil Dehydrogenase (NADP), Phenotype. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fluorouracil is among the most used antimetabolite drugs for the chemotherapeutic treatment of various types of gastrointestinal malignancies. Dihydropyrimidine dehydrogenase (DPYD) genotyping prior to fluorouracil treatment is considered standard practice in most European countries. Yet, current pre-therapeutic DPYD genotyping procedures do not identify all dihydropyrimidine dehydrogenase (DPD)-deficient patients. Alternatively, DPD activity can be estimated by determining the DPD phenotype by quantification of plasma concentrations of the endogenous uracil and thymine concentrations and their respective metabolites dihydrouracil (DHU) and dihydrothymine (DHT). Liquid chromatography - mass spectrometry (LC-MS) detection is currently considered as the most adequate method for quantification of low-molecular weight molecules, although the sample preparation method is highly critical for analytical outcome. It was hypothesized that during protein precipitation, the recovery of the molecule of interest highly depends on the choice of precipitation agent and the extent of protein binding in plasma. In this work, the effect of protein precipitation using acetonitrile (ACN) compared to strong acid perchloric acid (PCA) on the recovery of uracil, thymine, DHU and DHT is demonstrated. Upon the analysis of plasma samples, PCA precipitation showed higher concentrations of uracil and thymine as compared to ACN precipitation. Using ultrafiltration, it was shown that uracil and thymine are significantly (60-65 %) bound to proteins compared to DHU and DHT. This shows that before harmonized cut-off levels of DPD phenotyping can be applied in clinical practice, the analytical methodology requires extensive further optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymineUracilDihydrouracil Dehydrogenase (NADP)PhenotypeProtein BindingHumansChromatography, LiquidFluorouracilGenotypeDihydropyrimidine Dehydrogenase DeficiencyTandem Mass Spectrometry

Stichwörter der Autor:innen

Dihydropyrimidine Dehydrogenase ActivityProtein BindingProtein PrecipitationProtein UltrafiltrationThymineUracil

Substanzen

ThymineUracilDihydrouracil Dehydrogenase (NADP)Fluorouracildihydrouracil

Autor:innen und Institutionen

  • Laboratory of Chemical Biology, department of Biomedical Engineering, Eindhoven University of Technology, the Netherlands; Clinical Laboratory, Catharina Hospital Eindhoven, the Netherlands; Expert Center Clinical Chemi…
  • Clinical Laboratory, Catharina Hospital Eindhoven, the Netherlands; Clinical Laboratory Bernhoven, Siemens Healthineers, Uden, the Netherlands.
  • Laboratory of Chemical Biology, department of Biomedical Engineering, Eindhoven University of Technology, the Netherlands; Expert Center Clinical Chemistry Eindhoven, the Netherlands; Clinical Laboratory, Máxima Medical…
  • Department of Clinical Pharmacy, Catharina Hospital Eindhoven, the Netherlands; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Laboratory of Chemical Biology, department of Biomedical Engineering, Eindhoven University of Technology, the Netherlands; Expert Center Clinical Chemistry Eindhoven, the Netherlands.

Zitieren

APA

van den Wildenberg, S. A. H., Genet, S. A. A. M., Streng, A. S., Broeren, M. A. C., Deenen, M. J., van Dongen, J. L. J., Brunsveld, L., Scharnhorst, V., & van de Kerkhof, D. (2024). Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping. Journal of Pharmaceutical and Biomedical Analysis, 249, 116381. https://doi.org/10.1016/j.jpba.2024.116381

Vancouver

van den Wildenberg SAH, Genet SAAM, Streng AS, Broeren MAC, Deenen MJ, van Dongen JLJ, et al. Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping. Journal of Pharmaceutical and Biomedical Analysis. 2024;249:116381. doi:10.1016/j.jpba.2024.116381

BibTeX
@article{vandenWildenberg2024,
  author = {van den Wildenberg, Sebastian A H and Genet, Sylvia A A M and Streng, Alexander S and Broeren, Maarten A C and Deenen, Maarten J and van Dongen, Joost L J and Brunsveld, Luc and Scharnhorst, Volkher and van de Kerkhof, Daan},
  title = {Partial protein binding of uracil and thymine affects accurate dihydropyrimidine dehydrogenase (DPD) phenotyping},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2024},
  volume = {249},
  pages = {116381},
  doi = {10.1016/j.jpba.2024.116381}
}
Kostenlos starten →